Apolipoprotein C-III in atherosclerosis: from pathophysiological mechanisms to translational therapeutics
Apolipoprotein C-III (apoC-III) has emerged as a pivotal therapeutic target for lipid-lowering therapies, particularly for hypertriglyceridemia. However, its broader implications in the pathogenesis of atherosclerosis remain to be fully elucidated. ApoC-III is extensively studied for its classical role in modulating li...
Xiawen Yang, Shitao Wang, Wei Huang et al.
· Lipids in Health and Disease · 0 citations